Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.
Study Type
OBSERVATIONAL
Enrollment
100
Laparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function
Diet management,exercise,metformin,GLP-1 receptor agonists and other drugs which can lose weight.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
RECRUITINGTotal weight loss
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Serum creatinine
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Glomerular filtration rate
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Fasting blood glucose
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Average blood glucose from continuous glucose monitoring
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Postprandial 2-hour blood glucose
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
HbA1c
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Waist circumference and hip circumference
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Urinary microalbumin and other Urinalysis indexes
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
Medication status
Time frame: 1st, 3rd, 6th and 12th month after intervention, respectively.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.